Cannabinoids

FTC Approves Final Administrative Consent Order against Kushly Industries LLC and its Owner for Making Unsupported Health Claims for CBD Products

Retrieved on: 
Tuesday, July 6, 2021
Drugs, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Federal Trade Commission, False advertising

Following a public comment period, the Federal Trade Commission has approved a final administrative consent order against Scottsdale, Arizona-based Kushly Industries LLC (Kushly) and the companys owner, Cody Alt, for allegedly making false or unsupported health claims during the marketing and sale of cannabidiol (CBD) products to consumers.

Key Points: 
  • Following a public comment period, the Federal Trade Commission has approved a final administrative consent order against Scottsdale, Arizona-based Kushly Industries LLC (Kushly) and the companys owner, Cody Alt, for allegedly making false or unsupported health claims during the marketing and sale of cannabidiol (CBD) products to consumers.
  • According to the FTCs May 2021 complaint, Kushly and Alt made false or unsubstantiated claims that their CBD products could effectively treat or cure a host of conditionsfrom common ailments, like acne and psoriasis, to more serious diseases, including cancer and multiple sclerosis.
  • The final order settling the FTCs charges bars the respondents from the illegal conduct alleged in the complaint and requires them to pay the FTC $30,583.14the amount consumers paid Kushly for products sold using the deceptive marketing.
  • The Commission vote approving the final administrative consent order was 4-0-1, with Chair Lina Khan not participating.

FTC Approves Final Administrative Consent Order against Kushly Industries LLC and its Owner for Making Unsupported Health Claims for CBD Products

Retrieved on: 
Tuesday, July 6, 2021
Drugs, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Federal Trade Commission, False advertising

Following a public comment period, the Federal Trade Commission has approved a final administrative consent order against Scottsdale, Arizona-based Kushly Industries LLC (Kushly) and the companys owner, Cody Alt, for allegedly making false or unsupported health claims during the marketing and sale of cannabidiol (CBD) products to consumers.

Key Points: 
  • Following a public comment period, the Federal Trade Commission has approved a final administrative consent order against Scottsdale, Arizona-based Kushly Industries LLC (Kushly) and the companys owner, Cody Alt, for allegedly making false or unsupported health claims during the marketing and sale of cannabidiol (CBD) products to consumers.
  • According to the FTCs May 2021 complaint, Kushly and Alt made false or unsubstantiated claims that their CBD products could effectively treat or cure a host of conditionsfrom common ailments, like acne and psoriasis, to more serious diseases, including cancer and multiple sclerosis.
  • The final order settling the FTCs charges bars the respondents from the illegal conduct alleged in the complaint and requires them to pay the FTC $30,583.14the amount consumers paid Kushly for products sold using the deceptive marketing.
  • The Commission vote approving the final administrative consent order was 4-0-1, with Chair Lina Khan not participating.

CBD Global Issues Fourth Bi-Weekly Status Report Regarding Management Cease Trade Order

Retrieved on: 
Tuesday, July 6, 2021
Drugs, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, CBD, Cannabis, Hemp

As previously announced in the Corporations press releases, the Corporation applied for and was granted a management cease trade order in respect of the delayed Annual Filings (the MCTO) by the Alberta Securities Commission.

Key Points: 
  • As previously announced in the Corporations press releases, the Corporation applied for and was granted a management cease trade order in respect of the delayed Annual Filings (the MCTO) by the Alberta Securities Commission.
  • The MCTO does not affect the ability of the general investing public to trade in the Corporations listed common shares.
  • ABOUT CBD GLOBAL SCIENCES INC.
    CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS ( www.aethics.com ) and CANNAOIL ( www.cannaoilshop.com ), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products.
  • CBD Globals hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

Premium Delta-8 Products Launched by Exhale Wellness

Retrieved on: 
Monday, July 5, 2021
Songs, Drugs, Cannabinoids, Psychoactive drugs, Antiemetics, Delta-8-Tetrahydrocannabinol, Hemp, Wellness, Tetrahydrocannabinol, Exhale, Delta Air Lines

LOS ANGELES, July 5, 2021 /PRNewswire/ -- Exhale Wellness, a Los Angeles based hemp brand, has just launched its new premium line of Delta-8 products .

Key Points: 
  • LOS ANGELES, July 5, 2021 /PRNewswire/ -- Exhale Wellness, a Los Angeles based hemp brand, has just launched its new premium line of Delta-8 products .
  • Delta-8 THC products have experienced a meteoric rise in popularity these past few years, with Exhale Wellness being no stranger to this phenomenon.
  • Having brought several Delta-8 products to the market and gotten stellar reviews from customers, Exhale Wellness is currently one of the fastest growing brands in the space, and for a good reason.
  • Having been highly reviewed by its broad base of consumers, Exhale Wellness is recognized widely as a producer of premium quality hemp products.

Premium Delta-8 Gummies Launched By Exhale Wellness

Retrieved on: 
Friday, July 2, 2021
Appetite stimulants, Entheogens, Euphoriants, Drugs, Psychoactive drugs, Medical specialties, Cannabinoids, Antiemetics, Tetrahydrocannabinol, Gummy candy, Cannabis

They have recently launched a new product line that includes the Delta-8 THC gummies .

Key Points: 
  • They have recently launched a new product line that includes the Delta-8 THC gummies .
  • Exhale Wellness has seen an increasing number of individuals wanting to try this lighter version of weed.
  • Delta-8 gummies are not like the ordinary gummies you may have seen online.
  • Due to the convenience and popularity of edibles, Exhale decided to incorporate Delta-8 THC gummies to their line.

Area 52 Releases New Line of Premium delta 8 Products

Retrieved on: 
Tuesday, June 29, 2021
Psychoactive drugs, Electronic cigarettes, Tobacco, Smoking, Smoking cessation, Euphoriants, Cannabinoids, Tetrahydrocannabinol, Electronic cigarette, Vape shop

For starters, Area 52 has a cherry-flavored tincture that contains the same strong dose of 40 mg of delta 8 in every mL.

Key Points: 
  • For starters, Area 52 has a cherry-flavored tincture that contains the same strong dose of 40 mg of delta 8 in every mL.
  • However, Area 52 has made the biggest progress when it comes to its vape products.
  • The company's release of new premium delta 8 products also includes a disposable vape pen and a vape battery compatible with viscous extracts like Area 52's distillates.
  • Check out the new premium products offered by Area 52: https://Area52.com/products/
    Learn more about Area 52: https://Area52.com/about/
    delta 8 THC knowledge base: https://Area52.com/blog/

Charlotte's Web, Inc. to be Exclusive Hemp CBD Provider at Life Time

Retrieved on: 
Tuesday, June 29, 2021
Drugs, Anticonvulsants, Agriculture, Crops, Analgesics, Cannabidiol, Cannabinoids, Resorcinols, Charlotte's Web, Hemp, CBD

"This is a strategic relationship born of our shared valuesaround wellness, quality and sustainability," said Deanie Elsner,Charlotte's WebCEO and President.

Key Points: 
  • "This is a strategic relationship born of our shared valuesaround wellness, quality and sustainability," said Deanie Elsner,Charlotte's WebCEO and President.
  • "This partnership aligns well with our expansion strategy to reachconsumersin new environments across the U.S.We are excitedtowork with Life Time."
  • "Charlotte's Web is extremely well-respected in the CBD category and we are pleased to have them as our exclusive CBD retail partner."
  • Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Denver, Colorado, is the market leader in innovative hemp-derived cannabidiol ("CBD") wellness products under a family of brands which includes Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp.

Kadenwood Raises $50M to Accelerate Leadership Position in Shaping CBD Into Mainstream Wellness Category

Retrieved on: 
Tuesday, June 29, 2021
Drugs, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Wellness, Hemp, CBD

This latest funding round further accelerates the brand's mission to normalize CBD in health and wellness products.

Key Points: 
  • This latest funding round further accelerates the brand's mission to normalize CBD in health and wellness products.
  • In just the first half of 2021, Kadenwood has made a number of high-profile acquisitions, including CBD wellness brands Healist Advanced Naturals and Social CBD .
  • The deal effectively established Kadenwood as the largest supplier of vertically-integrated, hemp-derived cannabidiol (CBD) in the US, expanding the company's ability to scale production of its quality-driven CBD products.
  • Founded in 2019, Kadenwood is a privately held consumer products lifestyle company relentlessly focused on shaping CBD into a trusted and safe mainstream wellness category.

Medolife Rx Enters Partnership Agreement with Leading International Distributor, Brings Products to Mexico

Retrieved on: 
Tuesday, June 29, 2021
Drugs, Health care, Health sciences, Analgesics, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Medication, Over-the-counter drug

Products to be sold in Mexico through the agreement include Medolifes Immunapen product line, as well as its cannabidiol (CBD) and non-CBD line of pain relief/muscle creams.

Key Points: 
  • Products to be sold in Mexico through the agreement include Medolifes Immunapen product line, as well as its cannabidiol (CBD) and non-CBD line of pain relief/muscle creams.
  • Additionally, Medolife will use its patented polarization technology to enhance existing over-the-counter (OTC) pharmaceutical-grade white label products, such as male enhancement products and vitamins.
  • The first products to enter Mexico will be the CBD Muscle and Pain cream, with additional products following shortly, including tinctures and sprays.
  • Medolife Rx, Inc. is a global biotechnology company with operations in clinical research, manufacturing, and consumer products.

GW Pharma Sells for Billions; Psychedelic Company Following Similar Path

Retrieved on: 
Tuesday, June 29, 2021
Drugs, Health sciences, Health care, Herbalism, Medicinal plants, Cannabinoids, Natural phenols, Resorcinols, Cannabidiol, Jazz Pharmaceuticals, Medical cannabis, Legality of cannabis

Jazz Pharmaceuticals paying $7.2 billion for cannabis drug maker GW Pharma has investors looking at early-stage psychedelic companies.

Key Points: 
  • Jazz Pharmaceuticals paying $7.2 billion for cannabis drug maker GW Pharma has investors looking at early-stage psychedelic companies.
  • Tryp Therapeutics is one of only a handful of companies moving into Phase 2 clinical trials with a psychedelic compound.
  • GW was a true trendsetter with its Epidiolex (cannabidiol) for controlling seizures in rare forms of epilepsy.
  • A similar trend is underway with psychedelics, which are already benefiting from the path carved by cannabis drug development pioneers such as GW.